How Good Is “Good Enough”? The Case for Varying Standards of Evidence According to Need for New Interventions in HIV Prevention

American Journal of Bioethics 12 (6):21-30 (2012)
  Copy   BIBTEX

Abstract

In 2010, randomized controlled trials (RCTs) of two different biomedical strategies to prevent HIV infection had positive findings. However, despite ongoing very high levels of HIV infection in some countries and population groups, it has been made clear by regulatory authorities that the evidence remains insufficient to support either product being made available outside of research contexts in the developing world for at least two years. In addition, prevention trials in endemic areas will continue to test new interventions against placebo. But the judgments of evidentiary standards are never value-neutral. Using the recent trials and their contexts as case studies, we examine the basis for these decisions, which will potentially delay access to scientific innovation to the people who are most urgently in need of it

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 89,560

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Health care workers with hiv and a patient's right to know.Timothy F. Murphy - 1994 - Journal of Medicine and Philosophy 19 (6):553-569.
Hiv preventive vaccine research: Selected ethical issues.Christine Grady - 1994 - Journal of Medicine and Philosophy 19 (6):595-612.
A strategy of clinical tolerance for the prevention of hiv and aids in china.Yanguang Wang - 2000 - Journal of Medicine and Philosophy 25 (1):48 – 61.

Analytics

Added to PP
2012-06-01

Downloads
21 (#622,948)

6 months
3 (#431,291)

Historical graph of downloads
How can I increase my downloads?